Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
biotech
6
×
clinical trials
fda
6
×
life sciences
national blog main
eli lilly
boston blog main
indiana blog main
indiana top stories
national top stories
new york blog main
teva pharmaceutical
boston top stories
calcitonin gene-related peptide
chronic migraine
migraine
migraine research foundation
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
allergan
biohaven
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
indiana
lasmiditan
novartis
san diego blog main
san diego top stories
san francisco blog main
What
fda
new
6
×
drug
migraine
approval
class
medicines
won
approved
decades
developed
eli
lilly
nod
pain
starts
acquire
acute
addresses
adults
agreed
allergan
amgen
announced
arguments
big
billion
brings
candidates
cash
causes
cholesterol
commercialized
companies
company
competitors
compound
condition
deal
decision
Language
unset
Current search:
new
×
biotech
×
amgen
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines